Attached files
file | filename |
---|---|
EX-99.1 - TRANSCRIPT - SANUWAVE Health, Inc. | snwv_ex991.htm |
UNITED
STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of report (Date of earliest event reported): May 18,
2020
SANUWAVE Health, Inc.
(Exact Name of Registrant as Specified in Charter)
Nevada
|
|
000-52985
|
|
20-1176000
|
(State or Other Jurisdiction of Incorporation)
|
|
(Commission File Number)
|
|
(I.R.S. Employer Identification No.)
|
3360 Martin Farm Road, Suite 100
Suwanee, Georgia 30024
(Address of Principal Executive Offices, and Zip Code)
(770) 419-7525
Registrant’s Telephone Number, Including Area
Code
(Former Name or Former Address, if Changed Since Last
Report)
Check
the appropriate box below if the Form 8-K is intended to
simultaneously satisfy the filing obligation of the Registrant
under any of the following provisions:
☐
Written communications pursuant to Rule 425 under the Securities
Act (17 CFR 230.425)
☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act
(17 CFR 240.14a-12)
☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the
Exchange Act (17 CFR 240.14d-2(b))
☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the
Exchange Act (17 CFR 240.13e-4(c))
Securities
registered pursuant to Section 12(b) of the Act:
Title
of each class
|
Trading
Symbol(s)
|
Name of
each exchange on which registered
|
Common
Stock, par value $0.001
|
SNWV
|
OTCQB
|
Indicate
by check mark whether the registrant is an emerging growth company
as defined in Rule 405 of the Securities Act of 1933 (17 CFR
§230.405 of this chapter)
or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR
§240.12b-2 of this
chapter).
Emerging
growth company ☐
If an
emerging growth company, indicate by check mark if the registrant
has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided
pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02
Results of Operations and Financial Condition.
On May 18, 2020, SANUWAVE Health, Inc., a Nevada Corporation (the
“Company”), announced its financial results for the
first quarter ended March 31, 2020 and provided a business update
via conference call. A copy of the transcript of such call is
furnished as Exhibit 99.1 to this Form 8-K.
The information in this Item 2.02 of this Current Report on Form
8-K and the exhibits attached hereto shall not be deemed to be
“filed” for purposes of Section 18 of the Securities
Exchange Act of 1934, as amended, and shall not be deemed
incorporated by reference in any filing under the Securities Act of
1933, as amended, except as shall be expressly set forth by
specific reference in such filing.
Item
9.01
Financial Statements and Exhibits.
(d)
Exhibits.
Exhibit No.
|
|
Description
|
|
|
|
|
Transcript of the May 18, 2020, SANUWAVE Health, Inc. conference
call to discuss the fourth quarter and full fiscal year ended
December 31, 2019 financial results and provide a business
update.
|
|
|
|
|
|
|
|
2
SIGNATURES
Pursuant to the
requirements of the Securities Exchange Act of 1934, the registrant
has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
|
SANUWAVE
HEALTH, INC.
|
|
|
|
|
|
|
Dated:
May 27, 2020
|
By:
|
/s/ Lisa E. Sundstrom
|
|
|
Name:
|
Lisa E.
Sundstrom
|
|
|
Title:
|
Chief
Financial Officer
|
|
3